Clinical Trial Update: RenalGuard System and Contrast Media [Phase 3]

View source ↗

Summary

A Phase 3 trial update on the RenalGuard System used with contrast media in patients with Chronic Kidney Disease; study completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• RenalGuard System

Snippet

Sponsor: Clinica Mediterranea | Conditions: Chronic Kidney Disease | Phase 3 | Status: COMPLETED | Results posted: 2015-03-10